Drug:
Reaction: OFF LABEL USE
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26556590 |
US |
72 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 202 | 26556593 |
US |
33 | |
Drug ineffective, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 203 | 26556594 |
US |
57 | |
Rash, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 204 | 26556595 |
US |
31 | |
Drug effect less than expected, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 205 | 26556596 |
US |
||
Facial asymmetry, Wrong technique in product usage process, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 206 | 26556611 |
US |
||
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 207 | 26556614 |
US |
54 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 208 | 26556615 |
GB |
53 | |
Headache, Superficial vein prominence, Injection site bruising, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 209 | 26556616 |
CA |
39 | |
Dyspnoea at rest, Fatigue, Dyspnoea exertional, Dysphagia, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 210 | 26556654 |
US |
||
Eyelid ptosis, Visual impairment, Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 211 | 26556662 |
US |
61 | |
Headache, Dysphagia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 212 | 26556663 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 213 | 26556665 |
44 | ||
Hypoaesthesia, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 214 | 26556667 |
US |
47 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 215 | 26556670 |
US |
32 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 216 | 26556671 |
US |
41 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 217 | 26556672 |
US |
45 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 218 | 26556673 |
US |
56 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 219 | 26556674 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 220 | 26556676 |
US |
43 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 221 | 26556677 |
US |
51 | |
Drug ineffective for unapproved indication, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 222 | 26556678 |
US |
45 | |
Drug ineffective for unapproved indication, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 223 | 26556679 |
US |
34 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 224 | 26556698 |
US |
52 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 225 | 26556699 |
US |
58 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 226 | 26556700 |
US |
51 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 227 | 26556724 |
CA |
24 | 2 |
Ophthalmic herpes simplex, Off label use, |
||||
DUPILUMAB, DUPILUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 228 | 26556748 |
EU |
34 | 2 |
Metastasis, Lymphadenopathy, Off label use, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 229 | 26556753 |
EU |
21 | 1 |
Self-destructive behaviour, Screaming, Physical assault, Multiple-drug resistance, Off label use, |
||||
LACOSAMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, PERAMPANEL, VALPROIC ACID, POTASSIUM BROMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CLOBAZAM, STIRIPENTOL, |
||||
| 230 | 26556766 |
|||
Drug ineffective, Off label use, |
||||
BIMEKIZUMAB, |
||||
| 231 | 26556777 |
CA |
16 | 2 |
Colitis, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 232 | 26556786 |
US |
||
Fall, Off label use, |
||||
LENALIDOMIDE, |
||||
| 233 | 26556815 |
TW |
71 | 1 |
Upper gastrointestinal haemorrhage, Fungaemia, Neutropenia, Thrombocytopenia, Gastritis haemorrhagic, Gastric ulcer, Nausea, Vomiting, Diarrhoea, Underdose, Off label use, Off label use, |
||||
ZOLBETUXIMAB, DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, OLANZAPINE, |
||||
| 234 | 26556830 |
62 | 2 | |
Pancreatic neuroendocrine tumour, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AZATHIOPRINE, CYCLOSPORINE, LINAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 235 | 26556832 |
37 | 2 | |
Condition aggravated, Coagulopathy, Maternal exposure during pregnancy, Off label use, |
||||
URSODIOL, URSOSIOL, |
||||
| 236 | 26556836 |
40 | 1 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, |
||||
| 237 | 26556837 |
75 | 1 | |
Immunosuppressant drug level decreased, Drug interaction, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, APALUTAMIDE, LEUPROLIDE ACETATE, MAGNESIUM OXIDE, OLOPATADINE, |
||||
| 238 | 26556839 |
|||
Cytomegalovirus infection reactivation, Drug interaction, Off label use, |
||||
CYCLOSPORINE, LETERMOVIR, LETERMOVIR, |
||||
| 239 | 26556842 |
28 | 2 | |
Condition aggravated, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 240 | 26556852 |
US |
68 | 1 |
Portal venous gas, Off label use, Dyspnoea, Leukocytosis, Abdominal distension, Abdominal pain, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, APIXABAN, |
||||
| 241 | 26556853 |
US |
1 | |
Rheumatoid arthritis, Off label use, |
||||
TOCILIZUMAB, |
||||
| 242 | 26556914 |
CN |
74 | 1 |
Off label use, Immune-mediated myocarditis, |
||||
BEVACIZUMAB, METHYLPREDNISOLONE, |
||||
| 243 | 26556962 |
CH |
66 | 2 |
Pulmonary embolism, Osteopenia, Off label use, |
||||
LETROZOLE, LETROZOLE TABLETS, DENOSUMAB, |
||||
| 244 | 26556971 |
CN |
18 | 2 |
Off label use, Treatment failure, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OXAZEPAM, |
||||
| 245 | 26556976 |
EG |
2 | |
Palpitations, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, MELATONIN, |
||||
| 246 | 26556985 |
EU |
21 | 1 |
Self-destructive behaviour, Screaming, Multiple-drug resistance, Off label use, |
||||
LACOSAMIDE, LACOSAMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, PERAMPANEL, CLOBAZAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, POTASSIUM BROMIDE, STIRIPENTOL, VALPROIC ACID, |
||||
| 247 | 26556999 |
JP |
77 | 2 |
Restless legs syndrome, Therapy partial responder, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, VORTIOXETINE, VORTIOXETINE, ALPRAZOLAM, ALPRAZOLAM, SERTRALINE, ZOLPIDEM TARTRATE, |
||||
| 248 | 26557019 |
EG |
2 | |
Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 249 | 26557020 |
EG |
1 | |
Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 250 | 26557026 |
EG |
1 | |
Increased appetite, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, MELATONIN, |
||||
| 251 | 26557028 |
EG |
1 | |
Sedation, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, SUVOREXANT, |
||||
| 252 | 26557056 |
GB |
59 | 2 |
Remission not achieved, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 253 | 26557069 |
GB |
1 | |
Neutropenia, White blood cell count decreased, Eosinophil count decreased, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, |
||||
| 254 | 26557089 |
JP |
38 | 2 |
Restless legs syndrome, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, VORTIOXETINE, VORTIOXETINE, |
||||
| 255 | 26557132 |
BR |
||
Hyperkalaemia, Off label use, |
||||
NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, |
||||
| 256 | 26557135 |
CN |
73 | 1 |
Myelosuppression, Off label use, |
||||
OXALIPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 257 | 26557148 |
|||
Drug ineffective, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ADALIMUMAB, BUDESONIDE AND FORMOTEROL FUMARATE, FISH OIL, |
||||
| 258 | 26557160 |
IN |
63 | 1 |
Off label use, Hepatic lesion, Gastrointestinal haemorrhage, |
||||
ATEZOLIZUMAB, |
||||
| 259 | 26557169 |
US |
5 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 260 | 26557231 |
US |
||
Cardiac disorder, Off label use, |
||||
LENALIDOMIDE, |
||||
| 261 | 26557236 |
US |
2 | |
Off label use, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 262 | 26557254 |
US |
20 | 2 |
Off label use, |
||||
DUPILUMAB, RUXOLITINIB, |
||||
| 263 | 26557267 |
US |
||
Pneumonia, Product dose omission issue, Off label use, Respiratory syncytial virus infection, |
||||
LENALIDOMIDE, |
||||
| 264 | 26557272 |
BR |
75 | 2 |
Cholecystitis, Choking, Confusional state, Off label use, Cough, |
||||
DENOSUMAB, DENOSUMAB, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
| 265 | 26557288 |
CA |
38 | 2 |
Ear pruritus, Inappropriate schedule of product administration, Off label use, Pruritus, Throat irritation, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 266 | 26557309 |
US |
3 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 267 | 26557313 |
US |
4 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 268 | 26557338 |
US |
18 | 1 |
Drug ineffective, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, RISPERIDONE, RISPERIDONE, RISPERIDONE, ZIPRASIDONE, ZIPRASIDONE, ZIPRASIDONE, |
||||
| 269 | 26557398 |
US |
1 | |
Off label use, |
||||
ALIROCUMAB, |
||||
| 270 | 26557405 |
US |
52 | 2 |
Hypertension, Headache, Photophobia, Off label use, |
||||
| 271 | 26557434 |
US |
77 | 2 |
Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 272 | 26557499 |
5 | 2 | |
Condition aggravated, Off label use, |
||||
LORATADINE, LORATADINE ORAL, ALBUTEROL SULFATE, ALBUTEROL, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SULFASALAZINE, |
||||
| 273 | 26557520 |
US |
44 | |
Off label use, Systemic lupus erythematosus, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, BELIMUMAB, |
||||
| 274 | 26557538 |
US |
69 | 2 |
Off label use, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 275 | 26557542 |
US |
9 | 1 |
Off label use, |
||||
DUPILUMAB, |
||||
| 276 | 26557547 |
US |
73 | 2 |
Off label use, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 277 | 26557551 |
US |
80 | 1 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 278 | 26557558 |
US |
45 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 279 | 26557569 |
US |
75 | 2 |
Bronchitis, Dyspnoea, Blood glucose increased, Off label use, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 280 | 26557591 |
US |
1 | |
Off label use, |
||||
DUPILUMAB, |
||||
| 281 | 26557621 |
US |
11 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 282 | 26557640 |
CA |
52 | 2 |
Blood bilirubin increased, Bronchiectasis, Asthma-chronic obstructive pulmonary disease overlap syndrome, Hepatic enzyme increased, Total lung capacity increased, Schizophrenia, Oedema peripheral, Hypomania, Lung neoplasm malignant, Cardiac murmur, Nasal polyps, Chronic obstructive pulmonary disease, Rhinitis allergic, Cholelithiasis, Nausea, Off label use, Jaundice cholestatic, Sarcoidosis, Wheezing, Gastrooesophageal reflux disease, Hepatotoxicity, Vomiting, Pneumonia, Condition aggravated, Psychotic disorder, |
||||
FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, ACLIDINIUM BROMIDE, TIPRANAVIR, TIPRANAVIR, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, GLYCOPYRROLATE, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OLANZAPINE, OLANZAPINE, RISPERIDONE, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, VALPROATE SODIUM, TIOTROPIUM BROMIDE, CARBAMAZEPINE, CARBAMAZEPINE, TIPRANAVIR, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MEPOLIZUMAB, MONTELUKAST, MOMETASONE FUROATE, MEPOLIZUMAB, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, LAMIVUDINE, LAMIVUDINE ORAL, DIPHENHYDRAMINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCIUM CARBONATE, ANTACID, CICLESONIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LACTULOSE, ABACAVIR SULFATE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, LITHIUM, LITHIUM BROMATUM, SERTRALINE HYDROCHLORIDE, ZINC OXIDE, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT, ZINC OXIDE OINTMENT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN, ZINC OXIDE 20%, SKIN PROTECTANT, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM, PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, |
||||
| 283 | 26557699 |
US |
22 | 1 |
Hypertension, Abdominal pain upper, Vomiting, Off label use, |
||||
ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HCL, CETIRIZINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 284 | 26557756 |
US |
||
Patient dissatisfaction with treatment, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 285 | 26557757 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 286 | 26557758 |
US |
||
Dizziness, Fatigue, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 287 | 26557760 |
US |
||
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 288 | 26557761 |
US |
50 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 289 | 26557762 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 290 | 26557771 |
TR |
10 | |
Retinal tear, Off label use, |
||||
BEVACIZUMAB, |
||||
| 291 | 26557775 |
US |
43 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 292 | 26557777 |
US |
35 | |
Eyelid ptosis, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 293 | 26557779 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 294 | 26557783 |
US |
45 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 295 | 26557784 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 296 | 26557785 |
US |
44 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 297 | 26557790 |
US |
65 | |
Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 298 | 26557804 |
22 | ||
Drug dependence, Drug abuse, Serotonin syndrome, Suicide attempt, Anxiety disorder, Hyperhidrosis, Mydriasis, Hyperreflexia, Clonus, Off label use, Overdose, |
||||
| 299 | 26557806 |
|||
Off label use, Maternal exposure during breast feeding, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 300 | 26557807 |
EU |
47 | |
Toxic skin eruption, Pyrexia, Rash, Off label use, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, BISOPROLOL FUMARATE, NIFEDIPINE, AZATHIOPRINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28